Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

2.

Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax.

Midgley CM, Putz MM, Weber JN, Smith GL.

J Gen Virol. 2008 Dec;89(Pt 12):2992-7. doi: 10.1099/vir.0.2008/004440-0.

3.

Serological responses in humans to the smallpox vaccine LC16m8.

Johnson BF, Kanatani Y, Fujii T, Saito T, Yokote H, Smith GL.

J Gen Virol. 2011 Oct;92(Pt 10):2405-10. doi: 10.1099/vir.0.034207-0.

4.

Activity of vaccinia virus-neutralizing antibody in the sera of smallpox vaccinees.

Viner KM, Isaacs SN.

Microbes Infect. 2005 Apr;7(4):579-83.

PMID:
15848274
5.

Linear Epitopes in Vaccinia Virus A27 Are Targets of Protective Antibodies Induced by Vaccination against Smallpox.

Kaever T, Matho MH, Meng X, Crickard L, Schlossman A, Xiang Y, Crotty S, Peters B, Zajonc DM.

J Virol. 2016 Apr 14;90(9):4334-45. doi: 10.1128/JVI.02878-15.

6.

Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.

Berhanu A, Wilson RL, Kirkwood-Watts DL, King DS, Warren TK, Lund SA, Brown LL, Krupkin AK, Vandermay E, Weimers W, Honeychurch KM, Grosenbach DW, Jones KF, Hruby DE.

J Virol. 2008 Apr;82(7):3517-29. doi: 10.1128/JVI.01854-07.

7.

Capturing the natural diversity of the human antibody response against vaccinia virus.

Lantto J, Haahr Hansen M, Rasmussen SK, Steinaa L, Poulsen TR, Duggan J, Dennis M, Naylor I, Easterbrook L, Bregenholt S, Haurum J, Jensen A.

J Virol. 2011 Feb;85(4):1820-33. doi: 10.1128/JVI.02127-10.

8.

Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy.

Pütz MM, Alberini I, Midgley CM, Manini I, Montomoli E, Smith GL.

J Gen Virol. 2005 Nov;86(Pt 11):2955-60.

PMID:
16227216
9.

Unusual features of vaccinia virus extracellular virion form neutralization resistance revealed in human antibody responses to the smallpox vaccine.

Benhnia MR, Maybeno M, Blum D, Aguilar-Sino R, Matho M, Meng X, Head S, Felgner PL, Zajonc DM, Koriazova L, Kato S, Burton DR, Xiang Y, Crowe JE Jr, Peters B, Crotty S.

J Virol. 2013 Feb;87(3):1569-85. doi: 10.1128/JVI.02152-12.

10.
11.

Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice.

Kaufman DR, Goudsmit J, Holterman L, Ewald BA, Denholtz M, Devoy C, Giri A, Grandpre LE, Heraud JM, Franchini G, Seaman MS, Havenga MJ, Barouch DH.

J Virol. 2008 Jul;82(14):6829-37. doi: 10.1128/JVI.00353-08.

12.

The heterogeneity of human antibody responses to vaccinia virus revealed through use of focused protein arrays.

Duke-Cohan JS, Wollenick K, Witten EA, Seaman MS, Baden LR, Dolin R, Reinherz EL.

Vaccine. 2009 Feb 18;27(8):1154-65. doi: 10.1016/j.vaccine.2008.12.035.

13.

Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine.

Benhnia MR, McCausland MM, Su HP, Singh K, Hoffmann J, Davies DH, Felgner PL, Head S, Sette A, Garboczi DN, Crotty S.

J Virol. 2008 Apr;82(7):3751-68. doi: 10.1128/JVI.02244-07.

14.

An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection.

Morikawa S, Sakiyama T, Hasegawa H, Saijo M, Maeda A, Kurane I, Maeno G, Kimura J, Hirama C, Yoshida T, Asahi-Ozaki Y, Sata T, Kurata T, Kojima A.

J Virol. 2005 Sep;79(18):11873-91.

15.

Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model.

Meseda CA, Campbell J, Kumar A, Garcia AD, Merchlinsky M, Weir JP.

PLoS One. 2013 Jun 13;8(6):e67984. doi: 10.1371/journal.pone.0067984.

16.

Potent neutralization of vaccinia virus by divergent murine antibodies targeting a common site of vulnerability in L1 protein.

Kaever T, Meng X, Matho MH, Schlossman A, Li S, Sela-Culang I, Ofran Y, Buller M, Crump RW, Parker S, Frazier A, Crotty S, Zajonc DM, Peters B, Xiang Y.

J Virol. 2014 Oct;88(19):11339-55. doi: 10.1128/JVI.01491-14.

17.

Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease.

Golden JW, Zaitseva M, Kapnick S, Fisher RW, Mikolajczyk MG, Ballantyne J, Golding H, Hooper JW.

Virol J. 2011 Sep 20;8:441. doi: 10.1186/1743-422X-8-441.

18.

Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens.

Sakhatskyy P, Wang S, Zhang C, Chou TH, Kishko M, Lu S.

Virology. 2008 Feb 5;371(1):98-107.

19.

Extracellular enveloped vaccinia virus escapes neutralization.

Ichihashi Y.

Virology. 1996 Mar 15;217(2):478-85.

20.

Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.

Galmiche MC, Goenaga J, Wittek R, Rindisbacher L.

Virology. 1999 Feb 1;254(1):71-80.

Items per page

Supplemental Content

Support Center